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m1010136 DepreessdMoodattheTimeof HospitalizationisAssociatedwithGreeterLengthof Stsyin
AcuteMl
R.C. Ziegelstein,J.A. Fauerbach, D.P.Richter, S.S. Sordo, H.P.Zahalsky,
N.C. Chandia, D.E. Bush. Johns Hopkins Bsyviekvfvfedica/Centec
Ssltimore, MD, USA
Rehoapitelization is more common among psychologically distressed @I-
tiente (pte) with eorona~ artery disease. However, no prior study has exam-
ined whether depressed mood is related to length of stay (LOS) or medical
coats during the index hospitalization for acute myoeerdial infarction (Ml). We
evaluated 170 ptr,for DSM-IV depression or dysthmia (D/D) within 5 days
of their acute Ml and reviewed itemized UB-92 Universal Bills and medical
raeorda to determine LOS and costs. The hospital costs were primarily due
to room charges, pharmacy, radiology,and laboratory.The LOS of the 37 pts
(21.8% of sample) with D/D wasgreaterthan that of those without O/D (8.1+
0.2 vs. 8.8 +0.5, p < 0.05). The two groups did not differ with resp~t to age,
gender, or Ml severity (Killip class, Ml Ioeetion,or CPK). Chronic obstructive
pulmorrary disease (COP-D,p c 0.05) and hyperlipidemia (p -= 0.01) were
more common in those with D/D, whereas there was no difference in renal
failure or diabetes mellitus. There was a trend toward highereost of the index
hospiteiization in pte with D/D compared to those without DID ($15,988 vs.
$13,390 p = 0.07). Thus, pts with D/D at the time of their Ml have a greater
LOSthan those who do not. This does not appear to be related to Ml severity,
but may be related to the presence of other medical conditions. The etiology
and economic impact of these findings merit further evaluation, but these
observations suggest that early intervention in these pts may affect hospital
LOS for acute Ml.
I 1010-1371 PetientPreferenceforCmfiacCatheterizstion
viatheTransradialveTransfemoralApproach
C.J. Cooper, R.A. E1-Shiekh,L.D. Blaesing, M.W. Burket, J.A. Moore.
Medical College of Ohio, Toledo,OH, USA
Transredial catheterization (TRC) may have significant patient-perceived
benefiteovertransfemoral catheterization (TFC)byallowing early ambulation
and hospital discharge, and promoting early return to normal physical and
social functioning. The impact of these potential benefits on quality of life
(OOL) and thus, patient preference are unknown. The PREFER study is
a single center randomized comparison of TRC vs TFC. Preference and
QOL are measured with a self-administered questionnaire that includes the
Medical Outcomes Study SF-36. Procedure outcomes and length of stay
(LOS) are also measured. To date, 112 patients have been randomized.
Procedure duration, fluoroecopy time, and contrast usage were no different,
however the time to hemostasis and LOS were significantly shorter with TRC
(table).
Radial Femoral P
Prrx duration(rein) 25.1 l14.5 21.2* 13.4 na
Hemoetaeistime (rein) 30.2 + 19.7 46.2 &22.4 <0.001
LOS (hm) a.7* 11.2 18.7* 15.1 <0.wol
Fluorotime (rein) 6.6 + 6.4 6.0+5.3 ns
Contmet (ml) 132 k 35 146+ 50 ns
TRC isetrongly preferred by patients over TFC(< 0.0001) and associated
with Ieeaimmediate and overall discomfort (p= 0.007 for both) and improved
phyaioel and social functioning (p= 0.03 and 0.01) 1 week after catheteriza-
tion. Cone/usions:The current date demonstrate a strong patient preference
for TRC, most likely the result of Iesaened peri-procecfurd diaeomfori and
improved post-procedural phyaiealand social functioning.
11010-1381 ~:f::;&:~~cting A~end~n~at~ardis~
G.Lloyd,A. Cooper, J. Weinman 1, G. Jackaon. Department of Cardiology
Guy’s Hospital, London SEI, UK, 1Department of Psychology, United
M&ical& Dental Schools, London SE1, UK
Cardiac rehabilitation ia beneficial (CR) following myceardial infarction (Ml)
& coronary artery bypeea graft surgery (CABG) however uptake ia poor es-
pecially among women. This study examined patient characteristics& illness
perceptions (IP) es predictors of non attendance. Method Eligibie patienta
were offered CR aaked to complete a questionnaire regarding IP, practiesl
obstsclea to attending CR and risk factor awareneas, before discharge. Re-
sults: 111 patienta were evaluated: 31 (28%) women with a mean age 85,
and SO(i’p~o) men mean age 62. At discharge 31 (28%) deciined CR com-
pared with 74 (66%) who had not attended by three months. Among initial
daelinere reasons stated were not needing CR 8 (28%), transport difficulties
4 (13%), work commitment 4 (13). Patienta who did not attend were older,
mean age 65.4 and 58.54 (P < 0.01) and leas likely to be employed 18
(48.6%) Vs 19 (28%) (p = 0.03). Perceived control over illness was greater
in attenders (mean 25.29 and 22.96), (P < 0.01) and more attenders made
attribution to lifestyle (mean 3.48 Vs 2.75) (p < 0.01). Employment status
but not psychological factors wee confounded by age. Gender did not predict
non attendance. Course iocelity and inconvenient timea were moat frequently
cited aa reasons among non-attenders. Conclusion: CR uptake is poor with
Only ss~o patienta participating. It ia possible to predict those patienta leas
likely to attend as being older and retired, with lower perceptions of control
in illness and attribution of iliness to Iifeslyle. Women are as Iikeiy to attend
eS men. Greater targeting using psychological profiles may aliow more to
benefit from CR.
[1010-1391cOmpariaOnOfcOrOnavBypa eGratiin~ in
ComparableDefinedGeographicPopulationsin
CanadelUnitedStates
V.J. Yacyshyn, S.L. Kopecky,C.L. Leham, H.V. Schaff,”J.M. Naessens,
J.L. Cox, D.E. Johnstone. Mayo Clinic, l?ocfresteL MN, USA, Victoria
General Hospital, Nova Scotia, Canada
There has been much interest in comparison of the coronary bypasa greft-
ing (CABG) ayatem in the United States vs. Canada. However, very few
population-based comparisons have been done in defined geographic re-
gions. We have compared the CABG in Olmsted County (OC), Minneaote vs.
Nova Smtia, Canada (NSC)during a nine month period of 1992. The referrsl
base coming to single centers for CABG wea 100,000 in OC, Minnesota and
1 million in NSCrespectively. In the OC population there waa 35 per 100,000
and NSCwas 42 per 100,000. The mean age and mean ejection fraction
were the same in the populations. The mean time to surgery from the time
of decision to recommend bypass was different in the two populations (OC
6.4 weeks, NSC22.8 weeke). Other significant differences are shown on the
below graph (tripie Rx = nitrates, beta blockers, calcium channel blockers
therapy pre-CABG). Three percent of patients undergoing CABG in OC re-
quired upgrade to urgent status for bypass due to clinical deterioration vs.
12%of patients in NSC.The30day operative mortality was O%in each group
but the incidenceof mortality while waiting for CABG was O%in OC and 1.2Y0
in NSC.
Conclusions: 1) Incidence rates for CABG are similar in defined pQ-
ulations in the United Statea and Canada; 2) Patients undergoing CABG
generally have a higher incidence of triple vessel disease and a high inci-
dence of maximization of medical therapy before surgery; 3) There ia a slight
excess in mortality in Canadian patients while on the waiting list for CABG.
1IO1O-14OI ThelrtfluenceofhIsurenceTypeonthelJSeof
Procedures,MedicationsandHospitalOutcome
in PatientswithUnstableAngina
N.R. Evety, C.P.Cannon, C.B. Granger, D.J. Molitemo, F.V.Aguirre,
W.J. French, J.D. Talley,J. Bcdh, J.J. Ferguson, for the GUARANTEE
Investigator. Urriversiiyof Washington, Seattle, WA, USA
We evaluated the association between type of health inaurence and prooesa
of care in 610 patients with managed care and 1314 patients with fee-for-
setvice (FFS) inaurence admitted to 35hospitels with unstable angina (UAP).
Compared with managed care patients, FFS patienta, were older (8S.9
vs 81.3 yeare p < 0.001), and had higher rates of prior CHF (17% vs 12Y0
p = 0.012), but there were no other substantial differences in baseline char.
acteristiee. In univariate comparisons there was little difference in the use of
procedures, but FFSpetients were less Iikelyto be discharged on aspirin.
Managed Care FFS P value
EIT 17% 15% n~~----
Cath 470/o 50”A 0.179
PTCA 16°A 16”A 0.446
Stent@PTCA 34”/0 32”/. 0.672
CABG 7% 10”/0 0.016
ASA@discharge 74% 67% 0.001
Length-of-stay 3.7 days 4.3 days 0.027
HoapitalMortality 0.60/0 1.1”/4 0.511
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In, mukivariateanalyses, FFS patientswere more likelyto undergoan-
giography(Odds ratio= 1.3 ci 1.1–1.6), butthere was no differencein the
use of revascularization.We concludethat the processof care is aimilarin
FFS and managedesre patientswithUAP,althoughFFS patientsare more
likely to undergo angiography.
m1010141 TheEconomicConaequencesofsNewTherspyDependontheTypeof ReimbursementPlen
W.S. Weintraub,C. Warner,P.D. Mauldin,E. Becker,D. Gomea,J. Cook,
A. Kosinski,S. Boccuzzi,forthe RESTORE EconomicStudyGroup.Emory
University Atlanta, GA, USA
New therapieshave complexeconomic consaquencea. Consider the case
of an effective therapy to prevant restenosis after PTCA. Assume the initial
provider Coatis $12,000& restenosis (R) causes 20% repeat PTCAS,yield-
ing $2400 followup costs, or $14,400 total. Assume therapy decreasing R
50% costs $1000. Initial cost becomes $13,000 & followup $1300, a $100
savings total. Assume fee for service (FFS) providare charga cost +10%.
This describes a model of cost of R, varying in impact on provider & payer
depending on the type of reimbursement. (table, signs:+ cost, - savings).
Providers Pavers
Initial 6 Months initial 6 Months
Fee for Servica -$100 +$90 +$1100 -$1200
Packsgs Prica +$600 +$200 o -$1200
Capifsted +$1100 –$900 o 0
ReatenoaisPrevented
0.0 0.2 0.4 O.e 0.8 1.0
Under FFS, the payer takes the rick and provider consequences are
minimal. The aituation is reversed with cavitation.WithpackagePricin9, the
provider loses duetocost of therapy & Ieaaprocedures while the payer gains.
Sensitivity analyeis was used to further explore the model (see figure); in this
example under FFS, as therapy improved from no restenosis preventad
to 100% prevented, the payer savingsincreaaadfrom Oto $2400. A new
therapy may have considerable economic consequences, varying with time
& provider vs payer perspective.
El1o11 Stents: in-Stent Restenosis II
Tuesday,March 18, 1997, 3:00 p.m.–5:OOp.m.
AnaheimConventionCenter,Hall E
PresentationHour:3:00 p.m.-4:OOp.m.
m1011 1 IncompleteReetorstionof LuminalDimensionAfterPTCAin RestenosticStentedSegments:An
IntravascularUltrasoundAnalysis
G. G5rge, T. Konotza,E. Voagele,J. Ge, M. Haude, F. Liu,R. Erbal.Dep. of
Cardiology, University Hospital Essen, FRG, Germany
The mechanisms of PTCA in reetenosed etentad segments is incompletely
understood. Therefore, 24 patients with a > 50% diameter stenosis at six-
LurnerrAres n=24
10
&
P<0.0s
s
~ s
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STENT PTCA2
01 PTCA1 F-UP
month follow up (F-UP) were studied by intravascular ultrasound (IVUS,
30 MHz mechanical cathetera) and quantitative angiogrephy (QCA) after the
initial PTCA1,after stent implantation (Palmaz-Schatz, PS), at FU-P,and after
PTCA2 in reetenoeadstents. Thirty-one PS atents were implanted with IVUS
guidancein24 coronarylesions.Balloondiameterduringstent implantation
was 3.34 + 0.4 mm, and pressure 16 + 2 atm. Acute Iuminal area gain due
to stenting after PTCA was 4 mm2.At F-UP,minimal Iuminal diameter (QCA)
wae 1,3 * 0.5 mm. Stent area was unchanged (7.6 + 2 mm2 vs. 8 + 2.1
mmz at F.up). PTCAZ in the restenotic segments was performed with 11.1
+ 4.4 atm. Balloon size was unchanged compared with stent deployment.
Vessel area after PTCA2 increased from 19 & 5 mti to 21 + 7 mm2 and
stant area from 8 + 2.1 mm2to 9 + 2.5 mm2 (NS). The final lumen area was
significantly smaller compared to the acute procedure.
Conclusion: Intimal hyperplasia is the main cause for atent restenosis in
PS stents. PTCA2 resulted in only minor vessel and PS remodeling without
achieving the initial lumen diameters. This finding underlines the potential
role of debulking devices for treatment of in-stent restenosis.
11011-2I OPtimalCoronarYBalloonAngioPlastyvsStent
(OCBAS):PreliminaryResulteof a Randomized
Trial
A. Rodriguez, F.Ayala, C. Pardiilas, O. Santaera, M. Fernandez,
V. Bemardi, C. Mauvecin, I.F. Palacios. Anchorena and OtamemfiHoapifa/s,
Buenos Aires, Argentina, Massachusetts General Hospitsl, Boston, MA,
USA
Coronary stenting reducaa reetenoais in lesions with early deterioration (>
0.3 mm) in minimal Iuminal diameter (MLD) occurring within the fimt 24,hs
after suceeesfulPTCA (early loss). Lesions with no early loss after eucceseful
PTCA have a low restenoaia rate. This study was deaignad to compare im-
mediate results and restenosis rate of lesions treated with coronary stenting
vs. those treatad with optimal PTCA (good immediate result and no early
loss at 30 minutes post-PTCA angiography). From December of 1995 to July
of 1996116 patients were randomized to stent (n = 57) or PTCA (n = 59).
Primary success was achieved in all patients in the PTCA and in the stent
groups; 13.5% of the PTCA group patients cross over to stent due to sub-
optimal results or early lose. Immediate quantitative coronary angiographic
results follow:
PTCA Stent D
Reference Diameter 2.S k 0.6 2.9 + 0.6 na
MLD post-lntewention 2,2* 0,4 2.8 * 0.6 <0,001
MLD 30 minpost-PTCA 2.2 + 0,5 -
Acute Gain 1.4 1.9 < .02
Stenoaiapeat (%) 17* 10 11 k 10 <0,01
Conclusion.’1)Coronary stenting achieves greater acute gain than opti-
mal PTCA. 2) Angiographic restenosis data will be available at the time of
presentation.
1o11-3 TheAbsenceof D Alleleofthe ACEIDGenotype
PreventsRestenoeisAfterCoronaryStenting:A
QuantitativeAngiographicStudy
A. Dellavalle, G. Steffenino, F. Ribichini, G. Matullo 1, E. Colajanni
A. Vado, E. Uslenghi, A. Piazzal. Osp. S. Croce, Cuneo, Italy t Ist. di
Genetica, Univ di Torino, /tafy
The angiotensin converting enzyme (ACE) l/D polymorphism is of uncertain
aignifieartce in reetenosie after PTCA (R). From Dee. ’93 to Dec. ’95, 115
patients (p) (101 men, age61 + 9 y) were treatad with a first, elective, aingle-
veaael eoronaty Palmaz-Schafz stenting (CS) (130 etente in 115 lesions,
deployed at 14-20 atm with a balloon-vessel ratio = 1). P with ID diabetes,
aorto-ostial lesions, total occlusion >2 w&eks, leaion longer than 30 mm
DID (3S p) l/D (49 p) 1/1(26 p) p vslue (*)
D-ref (mm)
Ssfore PTCA 2.97 d 0.41 2,94 + 0,51 3.10 * 0.50 NS
After CS 3.15 * 0.36 3.14 * 0.39 3.29 + 0.67 NS
Follow-uP 2.94 + 0.44 2,S5 + 0,51 2,97 + 0.64 NS
MLD (mm)
Before PTCA 0.72 k 0.44 0.6S + 0.42 0.s3 * 0.54 FE
After CS 2.72 + 0.3S 2.67 & 0.35 2,85 + 0,65 NS
FOIIW-UP 1.s4 i 0.s2 1.ss * 0.s4 2,32 + 0,51 <0.05
“6DS
Safore PTCA 74* 14 74* 14 72& 13 NS
Aflar CS 15 i 7.7 15* S.1 13 h 6.S NS
Follow-uP 3S & 25 32+ 1S 26& 10 <0.05
% DS ? 50”A 12/36 (31”A) 6/49 (12%) 0/26 <0.C4XM
